Formulation Development of Otic In Situ Gel containing Lomefloxacin Hydrochloride
Abstract
Abstract
The present study was aimed at formulation development of a sustained release otic in situ gel of lomefloxacin hydrochloride for the treatment of chronic suppurative otitis media. Poloxamer 407 was used as the thermoreversible gelling agent. Poloxamer concentration in the range of 15–20% w/v was tried. Poloxamer 407 at 16% w/v gave satisfactory in situ gel forming formulations as it gelled near physiological temperature. Poloxamer 407 with various viscosity enhancing agents like methocel K100M, methocel K4M, carbopol 974P were tried in the range of 0.1–0.3% w/v. The formulations were evaluated for appearance/clarity, gelation temperature and gelling time, pH, rheological characteristics, drug content, in vitro drug release studies, ex vivo studies, release kinetics and stability studies. FT-IR spectroscopy was used to know drug and polymer incompatibilities. The viscosity of the formulations increased with increase in concentration of viscosity enhancers. In vitro release of selected formulations through synthetic membrane showed sustained release of drug over a period of 9 h. Ex vivo diffusion study for optimized formulation was also carried out through biological membrane. In case of pure drug, the release was more than 90% in 4 h and from in situ gel; the release was 55.38% at 9 h. Thus it can be a promising drug delivery system with sustained release and reduce frequency of administration providing better patient compliance.
Keywords: Lomefloxacin hydrochloride, in situ gel, poloxamer 407, gelation temperature, viscosity enhancing agents
Cite this Article
Niyas A M, Narayana Charyulu R, Jobin Jose. Formulation Development of Otic In Situ Gel containing Lomefloxacin Hydrochloride. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2016; 3(1): 20–29p.
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)
1. ________________
2. _______________
_3. ________________
4. ________________
The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
